1. Guidance for Industry: Scale-up and Post Approval Changes: Chemistry, Manufacturing, and Controls, In Vitro Dissolution Testing, and In Vivo Bioequivalence Documentation;Food and Drug Administration (FDA),1995
2. Proposal to Waive In Vivo Bioequivalence Requirements for the WHO Model List of Essentials Medicines Immediate Release Solid Oral Dosage Forms;World Health Organization (WHO),2006
3. Guideline on the Investigation of Bioequivalence;European Medicines Agency (EMA),2010
4. Guidance for Industry: Waiver of In Vivo Bioavailability and Bioequivalence Studies for Immediate-release Solid Oral Dosage Forms Based on a Biopharmaceutical Classification System;Food and Drug Administration (FDA),2015
5. WHO Expert Committee on Specifications for Pharmaceutical Preparations 49th Report;World Health Organization (WHO),2015